David Martin-Herrero
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition.
Journal: Nature communications
Published: August 29, 2018
EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.
Journal: International journal of cancer
Published: August 24, 2017
Correction: The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin.
Journal: Oncotarget
Published: July 05, 2017
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1.
Journal: Cancer letters
Published: September 22, 2016
The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma.
Journal: Oncotarget
Published: May 18, 2016
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report.
Journal: Clinical sarcoma research
Published: February 17, 2016
Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway.
Journal: Oncotarget
Published: December 22, 2015
Cell Death Identification in Anticancer Therapy-Response.
Journal: Cancer research
Published: June 04, 2015
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin.
Journal: Oncotarget
Published: March 13, 2015
The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy.
Journal: Frontiers in oncology
Published: January 16, 2015
Last Updated: 09/26/2026